Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Pancreatic Neoplasms 14Colorectal Neoplasms 11Rectal Neoplasms 6Stomach Neoplasms 5Colonic Neoplasms 4Ovarian Neoplasms 3Neoplasm Metastasis 3Esophageal Neoplasms 3Adenocarcinoma Of Esophagus 3Urinary Bladder Neoplasms 2Pancreatic Adenocarcinoma 2Lung Neoplasms 2Gastrointestinal Neoplasms 2Clinical Stage I Gastric Cancer AJCC v8 2Borderline Resectable Pancreatic Adenocarcinoma 2Appendiceal Neoplasms 2Uterine Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1Triple Negative Breast Neoplasms 1Thrombocytosis 1Somatostatinoma 1Sinonasal undifferentiated carcinoma 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peritoneal Neoplasms 1Paranasal Sinus Neoplasms 1Neoplasms 1Nasopharyngeal Carcinoma 1

Interventions

Gemcitabine 8pembrolizumab 5Cisplatin 5enfortumab vedotin 3avelumab 3Specimen Handling 3Nivolumab 3Magnetic Resonance Spectroscopy 3Carboplatin 3vinflunine 2Radiotherapy 2Nephroureterectomy 2Immunoglobulin G 2Doxorubicin 2Disulfides 2vandetanib 1tremelimumab 1tocilizumab 1tamibarotene 1relatlimab 1pegfilgrastim 1merphos 1guadecitabine 1genexol-PM 1enzalutamide 1durvalumab 1dehydroftorafur 1atezolizumab 1abexinostat 1Vitamin D 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Ureteral Neoplasms × dehydroftorafur × Clear all
NCT03617913 2023-01-06

Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer

Mayo Clinic

Phase 2 Completed
2 enrolled 8 charts
Genitourinary

Urinary Bladder Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡